CONSOLIDATED  BALANCE SHEETS S50 Edwards Lifesciences Corporation December 31, (in millions, except share data) 2002 2001 Assets Current assets Cash and cash equivalents $ 34.2 $ 47.7 Accounts receivable, net of allowances of $5.5 and $4.3 88.3 85.3 Other receivables 20.1 15.3 Inventories, net 111.8 86.6 Deferred income taxes 27.6 18.2 Prepaid expenses 21.0 18.9 Other current assets 23.4 20.0 Total current assets 326.4 292.0 Property, plant and equipment, net 209.4 187.8 Goodwill 333.8 333.8 Other intangible assets, net 61.9 68.6 Investments in unconsolidated affiliates 23.5 92.9 Deferred income taxes 38.8 — Other assets 14.4 7.8 Total assets $ 1,008.2 $ 982.9 Liabilities and Stockholders’ Equity Current liabilities Accounts payable and accrued liabilities $ 197.9 $ 183.5 Short-term debt — 1.1 Total current liabilities 197.9 184.6 Long-term debt 245.5 309.8 Other liabilities 25.4 29.8 Commitments and contingent liabilities Stockholders’ Equity Preferred stock, $0.01 par value, authorized 50,000,000 shares, no shares outstanding — — Common stock, $1.00 par value, authorized 350,000,000 shares,  60,177,275 and 59,327,872 shares outstanding 60.2 59.3 Additional contributed capital 412.0 287.2 Retained earnings 143.4 87.7 Accumulated other comprehensive income (44.7) 25.2 Common stock in treasury, at cost (31.5) (0.7) Total stockholders’ equity 539.4 458.7 Total liabilities and stockholders’ equity $ 1,008.2 $ 982.9 The accompanying notes are an integral part of these consolidated financial statements.